Cardiovascular Surgery News and Research

RSS

Saint Luke's Hospital opens Charles & Barbara Duboc Cardio Health & Wellness Center

The Charles & Barbara Duboc Cardio Health & Wellness Center is ushering in a new era for preventive cardiac care at Saint Luke's Hospital.

6 Jul 2013

UH and Case Western Reserve University to develop diagnostic tests to determine HIV drug resistance

Case Western Reserve University has signed an exclusive worldwide licensing agreement granting University Hospitals Case Medical Center rights to a series of diagnostic tests to determine drug resistance and co-receptor tropism in human immunodeficiency virus.

2 Jul 2013

UH Eye Institute to use Argus II Retinal Prosthesis System to treat patients with RP

University Hospitals Eye Institute will be one of the first medical centers in the United States to offer the Argus II Retinal Prosthesis System.

28 Jun 2013

Children with congenital heart disease require higher levels of Vitamin D intake prior to surgery

Until now, there has been no research dedicated to the importance of Vitamin D supplementation in children with congenital heart disease (CHD). However, over the past few years, researchers at the Children's Hospital of Eastern Ontario (CHEO) Research Institute and Cardiovascular Surgery Program teamed with the Canadian Critical Care Trials Group to understand the impact of cardiac surgery on the Vitamin D status of infants and children, to be printed next month in Anesthesiology.

27 Jun 2013

Researchers launch clinical trial on stem cells to prevent amputations in end stage PAD

University Hospitals Case Medical Center clinical researchers have launched an innovative clinical trial, unique in its design, which will evaluate the ability of a patient's own stem cells to prevent leg amputations in end stage peripheral arterial disease (PAD).

20 Jun 2013

Ibrutinib shows remarkable promise for treatment of mantle cell lymphoma

In a major international study led by researchers at The University of Texas MD Anderson Cancer Center, the targeted therapy ibrutinib continues to show remarkable promise for the treatment of relapsed or refractory mantle cell lymphoma (MCL).

20 Jun 2013

UHCMC physicians design new procedure to clear blocked carotid arteries, prevent stroke

Physicians at University Hospitals Case Medical Center enrolled their first patients in the ROADSTER Study, a global, multicenter clinical trial evaluating a novel, less-invasive procedure to help clear blockages in carotid arteries and prevent strokes.

19 Jun 2013

AtriCure's Bipolar RF Ablation System shows promising results in persistent Afib patients

A leading German cardiovascular heart center reported promising mid-term results for the surgical treatment of persistent atrial fibrillation during last week's International Society for Minimally Invasive Cardiothoracic Surgery meeting being held in Prague, Czech Republic.

18 Jun 2013

Cerus enrolls patient in two European clinical trials for INTERCEPT System for RBCs

Cerus Corporation announced today that it has initiated patient enrollment in two European Phase III clinical trials for the INTERCEPT System for red blood cells.

11 Jun 2013

ECMO may show promise as rescue strategy for select cardiac arrest patients

Extracorporeal membrane oxygenation, a procedure traditionally used during cardiac surgeries and in the ICU that functions as an artificial replacement for a patient's heart and lungs, has also been used to resuscitate cardiac arrest victims in Japan, Taiwan, and South Korea.

17 May 2013

UHCMC researchers to present data on patient and physician barriers to clinical trials

Researchers from University Hospitals Case Medical Center's Seidman Cancer Center will present findings from two studies evaluating new technologies designed to address common barriers to patient enrollment in clinical trials.

16 May 2013

Loyola University Medical Center physicians deploy aortic valve through patient's abdomen

In a first-of-its-kind procedure in the United States, Loyola University Medical Center physicians have deployed an aortic valve by going through a patient's abdomen.

18 Apr 2013

FDA approves CryoLife's next generation HeRO device

CryoLife, Inc., a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today that it has received U.S. Food and Drug Administration 510(k) clearance for a next generation HeRO (Hemodialysis Reliable Outflow) device.

5 Apr 2013

On and off-pump coronary artery bypass surgery equally safe, effective for older patients

Older patients did as well after undergoing coronary bypass surgery off-pump as they did with the more costly "on-pump" procedure using a heart-lung machine to circulate blood and oxygen through the body during surgery, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session.

12 Mar 2013

STS presents Earl Bakken Scientific Achievement Award to Stanford University professor

The Society of Thoracic Surgeons presented the Earl Bakken Scientific Achievement Award to D. Craig Miller, MD on Tuesday morning during the General Session at the STS 49th Annual Meeting.

31 Jan 2013

Sanofi introduces LeGoo gel to temporarily stop blood flow during cardiovascular surgery

Sanofi US announced the commercial launch of LeGoo, a biopolymer gel that allows surgeons to temporarily stop blood flow during surgery without the use of clamps, elastic loops or other conventional occlusion devices, which may increase risk of trauma to blood vessels.

30 Jan 2013

Sorin Group’s Mitroflow valve receives Japanese PMDA approval

Sorin Group, a global medical company and a leader in the treatment of cardiovascular diseases, announced today that it received the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) approval for the Mitroflow Aortic Pericardial Heart Valve.

4 Dec 2012

Respiratory physical therapy before cardiac surgery may reduce serious pulmonary complications

Patients who practice respiratory physical therapy exercises before elective cardiac surgery may reduce serious pulmonary complications later, finds a new evidence review from The Cochrane Library.

30 Nov 2012

FDA approves HeartWare Ventricular Assist System to treat end-stage heart failure

HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that it has received approval from the United States Food and Drug Administration (FDA) for the HeartWare Ventricular Assist System as a bridge to heart transplantation in patients with end-stage heart failure.

20 Nov 2012

St. Luke's unveils Discovery IGS 730 Hybrid OR from GE Healthcare

St. Luke's University Hospital unveiled the Discovery IGS 730 Hybrid OR from GE Healthcare today, becoming the first hospital in the United States to offer this exciting new technology.

17 Nov 2012